Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.55 |
| ▸ | PPARG | P37231 | 19/20 | 0.49 |
| ▸ | PPARA | Q07869 | 19/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4726473 | 0.89 | SMN1; SMN2 (0.57) | SMN1; SMN2PPARGPPARA | |
| SCHEMBL4726475 | 0.89 | SMN1; SMN2 (0.57) | SMN1; SMN2PPARGPPARA | |
| SCHEMBL4728216 | 0.83 | PPARA (0.50) | SMN1; SMN2PPARGPPARA | |
| SCHEMBL5010216 | 0.82 | SMN1; SMN2 (0.56) | SMN1; SMN2PPARGPPARA | |
| SCHEMBL6113119 | 0.80 | SMN1; SMN2 (0.54) | SMN1; SMN2PPARGPPARA | |
| SCHEMBL6113115 | 0.80 | SMN1; SMN2 (0.54) | SMN1; SMN2PPARGPPARA | |
| SCHEMBL2231218 | 0.79 | SMN1; SMN2 (0.63) | SMN1; SMN2PPARGPPARA | |
| SCHEMBL2561889 | 0.77 | PPARG (0.68) | SMN1; SMN2PPARGPPARA | |
| Methane SCHEMBL27838357 | 0.77 | SMN1; SMN2 (0.61) | SMN1; SMN2PPARGPPARA | |
| SCHEMBL5004494 | 0.77 | SMN1; SMN2 (0.54) | SMN1; SMN2PPARGPPARA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2008035359-A2 | OXIMINOPHENOXYALKANOIC ACID AND PHENYLALKANOIC ACID DERIVATIVES | CADILA HEALTHCARE LIMITED (IN) | 2008-03-27 | — | — | WO | claimed |
| WO-2008035359-A2 | OXIMINOPHENOXYALKANOIC ACID AND PHENYLALKANOIC ACID DERIVATIVES | CADILA HEALTHCARE LIMITED (IN) | 2008-03-27 | — | — | WO | disclosed |